3 ms·
This is something the FDA should have done automatically at the time the issued the EUA or full authorization. That is preparing and releasing all the data for
by bluGill 5y ago
This is something the FDA should have done automatically at the time the issued the EUA or full authorization. That is preparing and releasing all the data for independent review should be part of their review. there is no reason the FDA should try to keep this secret in the first place, and a number of reasons they should make it available.
That doing their job is hard isn't an excuse to not do it.
- lalaland1125 5y ago> no reason the FDA should try to keep this secret in the first place Personal medical information, especially as part of clinical trials, is some of the most legally protected data in the world. You can't just hand it out to people. And even with medical grade redaction (which is very expensive) there is always a risk of leaked information getting past the filters. I just find it funny that HN, usually a place very concerned with privacy, is now suddenly demanding the release of some of the most private and personal information of tens if not hundreds of thousands of individuals.
- core-utility 5y agoI don't believe he's arguing for the release of personal medical information, he's arguing for the automatic release of the documents redacted of personal medical information. In other words, the FDA should have been prepared for this all along. Additionally, if Pfizer were to have been told to be prepared to redact PII, I'm sure authors could have easily marked PII during authoring for quick identification and removal. Someone had to write this stuff, it didn't just appear in the ether.
- kube-system 5y agoIt's not that easy. The amount of information that the someone at the FDA might need to do their job is definitely not bounded by the limitations in FOIA, they need the details. The FOIA process has to happen afterwards by the FDA anyway by law, regardless of what Pfizer provided. Additionally, the healthcare professionals who collected the data are also not qualified to do FOIA compliance, nor is it always possible to tell if a single data element will be PII after it is compiled with other information at a later date, because PII can be indirectly inferred from other elements of information.
- tzs 5y agoAll the data relevant to the EUA or full authorization is available. The data not available is personal medical information of patients that has to be collected for and during trials because some of it might become important if something bad happens during the trial. E.g, if some trial patients suffer serious adverse reactions you want to have all their medical information on hand to better understand what went wrong. For a trial that goes well the vast majority of that information turns out to not have been looked at or used.